期刊的影响因子--文章列表

期刊文章列表
Rania Awad¹，Avi Avital²，Alejandro Sosnik¹（Laboratory of Pharmaceutical Nanomaterials Science，Department of Materials Science and Engineering，Technion-Israel Institute of Technology；Behavioral Neurobiology Laboratory，Department of Occupational Therapy，Faculty of Social Welfare and Health Sciences，University of Haifa）.Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders[J].Acta Pharmaceutica Sinica B,2023,第5期 Shuye Lin¹，Hanli Xu²，Lin Qin³，Mengdi Pang²，Ziyu Wang¹，Meng Gu¹，Lishu Zhang¹，Cong Zhao¹，Xuefeng Hao¹，Zhiyun Zhang¹，Weimin Ding³，Jianke Ren⁴，Jiaqiang Huang^1,2（Cancer Research Center，Beijing Chest Hospital，Capital Medical University，Beijing Tuberculosis and Thoracic Tumor Institute；College of Life Sciences & Bioengineering，Beijing Jiaotong University；Department of Endoscopic Diagnosis and Treatment，Beijing Chest Hospital，Capital Medical University，Beijing Tuberculosis and Thoracic Tumor Institute；CAS Key Laboratory of Computational Biology，Shanghai Institute of Nutrition and Health，University of Chinese Academy of Sciences，Chinese Academy of Sciences）.UHRF1/DNMT1—MZF1 axis-modulated intragenic site-specific CpGI methylation confers divergent expression and opposing functions of PRSS3 isoforms in lung cancer[J].Acta Pharmaceutica Sinica B,2023,第5期 Duo Xu^1,2,3，Fan Yang^2,3，Jiayao Chen^1,3，Tianxing Zhu^2,3，Fen Wang⁴，Yitai Xiao^2,3，Zibin Liang³，Lei Bi³，Guolong Huang³，Zebo Jiang^2,3，Hong Shan^1,3，Dan Li^2,3（Center for Interventional Medicine，the Fifth Affiliated Hospital，Sun Yat-sen University；Department of Nuclear Medicine，the Fifth Affiliated Hospital，Sun Yat-sen University；Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging，the Fifth Affiliated Hospital，Sun Yat-sen University；Department of Pathology，the First Affiliated Hospital，Sun Yat-sen University）.Novel STING-targeted PET radiotracer for alert and therapeutic evaluation of acute lung injury[J].Acta Pharmaceutica Sinica B,2023,第5期 Chuan Hu，Yujun Song，Yiwei Zhang，Siqin He，Xueying Liu，Xiaotong Yang，Tao Gong，Yuan Huang，Huile Gao（Key Laboratory of Drug Targeting and Drug Delivery Systems，West China School of Pharmacy，Sichuan University）.Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome[J].Acta Pharmaceutica Sinica B,2023,第5期 Lijuan Ma¹，Jing Zhang¹，Ling Lin¹，Tuanjie Wang²，Chaofu Ma¹，Xiaomeng Wang¹，Mingshuang Li¹，Yanjiang Qiao¹，Yongxiang Wang³，Guimin Zhang⁴，Zhisheng Wu¹（Beijing University of Chinese Medicine，Engineering Research Center for Pharmaceutics of Chinese Materia Medica and New Drug Development，Ministry of Education；Jiangsu Kanion Pharmaceutical Co.Ltd.，State Key Laboratory of New Technology in Pharmaceutical Process of Traditional Chinese Medicine；Yangtze River Pharmaceutical (Group) Co.Ltd.，State Pharmaceutical Engineering Technology Research Center of Traditional Chinese Medicine；Lunan Pharmaceutical Group Co.Ltd.，State Key Laboratory of Generic Technology of Traditional Chinese Medicine）.Data-driven engineering framework with AI algorithm of Ginkgo Folium tablets manufacturing[J].Acta Pharmaceutica Sinica B,2023,第5期 Huitong Ruan^1,2，Yongfang Li³，Cheng Wang⁴，Yixu Jiang⁴，Yulong Han^5,6，Yiwei Li^5,6，Dandan Zheng¹，Jing Ye⁴，Gang Chen²，Guo-yuan Yang⁴，Lianfu Deng¹，Ming Guo⁵，Xingcai Zhang⁶，Yaohui Tang⁴，Wenguo Cui¹（Department of Orthopaedics，Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases，Shanghai Institute of Traumatology and Orthopaedics，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine；Jiaxing Key Laboratory of Basic Research and Clinical Translation on Orthopedic Biomaterials，Department of Orthopaedics，the Second Affiliated Hospital of Jiaxing University；Department of Rehabilitation Medicine，Ruijin Hospital，School of Medicine，Shanghai Jiao Tong University；Med-X Research Institute and School of Biomedical Engineering，Shanghai Jiao Tong University；School of Engineering，Massachusetts Institute of Technology；School of Engineering and Applied Sciences，Harvard University）.Click chemistry extracellular vesicle/peptide/chemokine nanocarriers for treating central nervous system injuries[J].Acta Pharmaceutica Sinica B,2023,第5期 Fuhua Wu，Shuang Luo，Yongshun Zhang，Yangsen Ou，Hairui Wang，Zhaofei Guo，Chunting He，Shuting Bai，Penghui He，Min Jiang，Xiaoyan Chen，Guangsheng Du，Xun Sun（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity[J].Acta Pharmaceutica Sinica B,2023,第5期 Shameer M.Kondengadan，Shubham Bansal，Ce Yang，Dongning Liu，Zach Fultz，Binghe Wang（Department of Chemistry and Center for Diagnostics and Therapeutics，Georgia State University）.Click chemistry and drug delivery：A bird’s-eye view[J].Acta Pharmaceutica Sinica B,2023,第5期 Hongjuan Zhang¹，Ying Chen¹，Yu Zhang¹，Luyao Qiao¹，Xiangyin Chi¹，Yanxing Han¹，Yuan Lin¹，Shuyi Si²，Jiandong Jiang^1,2（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe[J].Acta Pharmaceutica Sinica B,2023,第5期 Kan Xing Wu¹，Thinesshwary Yogarajah^2,3，Marcus Wing Choy Loe²，Parveen Kaur²，Regina Ching Hua Lee²，Chee Keng Mok⁴，Yi Hao Wong⁴，Patchara Phuektes⁵，Li Sze Yeo²，Vincent T.K.Chow^2,3，Yong Wah Tan⁶，Justin Jang Hann Chu^2,5,6,4（Lee Kong Chian School of Medicine，Nanyang Technological University；Department of Microbiology and Immunology，Yong Loo Lin School of Medicine，National University Health System，National University of Singapore；Infectious Disease Programme，Yong Loo Lin School of Medicine，National University of Singapore；NUSMed Biosafety Level 3 Core Facility，Yong Loo Lin School of Medicine，National University of Singapore；Department of Pathobiology，Faculty of Veterinary Medicine，Khonkaen University；Institute of Molecular and Cell Biology，Agency for Science，Technology and Research(A~*STAR)）.The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses[J].Acta Pharmaceutica Sinica B,2023,第5期 Wen Zhu¹，Yang Wang¹，Liangyin Lv¹，Hui Wang¹，Wenqiang Shi¹，Zexin Liu¹，Mingzhe Zhou²，Jianwei Zhu¹，Huili Lu¹（Engineering Research Center of Cell and Therapeutic Antibody，Ministry of Education，School of Pharmacy，Shanghai Jiao Tong University；State Key Laboratory of Genetic Engineering，School of Life Science，Fudan University）.Universal chimeric Fcγ receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy[J].Acta Pharmaceutica Sinica B,2023,第5期 Endong Zhang¹，Philana Phan¹，Zongmin Zhao^1,2（Department of Pharmaceutical Sciences，College of Pharmacy，University of Illinois Chicago；Translational Oncology Program，University of Illinois Cancer Center）.Cellular nanovesicles for therapeutic immunomodulation：A perspective on engineering strategies and new advances[J].Acta Pharmaceutica Sinica B,2023,第5期 Yub Raj Neupane^1,2，Harish K.Handral³，Syed Abdullah Alkaff⁴，Wei Heng Chng^1,5，Gopalakrishnan Venkatesan^1,6，Chenyuan Huang^7,8,9，Choon Keong Lee¹，Jiong-Wei Wang^7,8,9,10，Gopu Sriram¹¹，Rhonnie Austria Dienzo¹²，Wen Feng Lu³，Yusuf Ali^12,13，Bertrand Czarny^4,12，Giorgia Pastorin^1,5,14（Department of Pharmacy，National University of Singapore；Department of Pharmaceutical Sciences and Experimental Therapeutics，the University of Iowa College of Pharmacy；Department of Mechanical Engineering，National University of Singapore；School of Materials Science and Engineering，Nanyang Technological University；Integrative Sciences and Engineering Programme，NUS Graduate School，National University of Singapore；Antimicrobial Resistance Interdisciplinary Research Group(AMR-IRG)，Singapore-MIT Alliance for Research and Technology；Department of Surgery，National University of Singapore；Cardiovascular Research Institute，National University Heart Centre；Nanomedicine Translational Research Programme，Centre for Nano Medicine，Yong Loo Lin School of Medicine，National University of Singapore；Department of Physiology，National University of Singapore；Faculty of Dentistry，National University of Singapore；Lee Kong Chian School of Medicine，Nanyang Technological University；Singapore Eye Research Institute(SERI)，Singapore General Hospital；NUSNNI-Nano Core，National University of Singapore）.Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound healing[J].Acta Pharmaceutica Sinica B,2023,第5期 Yonghyun Choi¹，Wooic Son^2,3，Youngpin Han^2,3，Jayoung Chae¹，Chul-Su Yang^2,3，Jonghoon Choi¹（School of Integrative Engineering，Chung-Ang University；Department of Molecular & Life Science，Hanyang University；Center for Bionano Intelligence Education and Research，Hanyang University）.Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma[J].Acta Pharmaceutica Sinica B,2023,第5期 Yunfei Yin¹，Mingyue Tan¹，Lianhua Han¹，Lei Zhang¹，Yue Zhang¹，Jun Zhang¹，Wanqian Pan¹，Jiaxiang Bai^1,2,3，Tingbo Jiang¹，Hongxia Li¹（Department of Cardiology，the First Affiliated Hospital of Soochow University；Department of Orthopedics，the First Affiliated Hospital of Soochow University；Department of Orthopedics，the First Affiliated Hospital of USTC，Division of Life Sciences and Medicine，University of Science and Technology of China）.The hippo kinases MST1/2 in cardiovascular and metabolic diseases：A promising therapeutic target option for pharmacotherapy[J].Acta Pharmaceutica Sinica B,2023,第5期 Boya Chen¹，Haiying Zhu¹，Bo Yang^1,2，Ji Cao^1,2,3（Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center of Zhejiang University）.The dichotomous role of immunoproteasome in cancer：Friend or foe?[J].Acta Pharmaceutica Sinica B,2023,第5期 Jiang Xu^1,2，Shuai Guo^1,2，Xianmei Yin¹，Mingqian Li³，He Su⁴，Xuejiao Liao⁵，Qiushi Li²，Liang Le²，Shiyu Chen^1,2，Baosheng Liao⁴，Haoyu Hu²，Juan Lei²，Yingjie Zhu⁶，Xiaohui Qiu⁴，Lu Luo²，Jun Chen，Ruiyang Cheng²，Zhenzhan Chang⁸，Han Zhang⁹，Nicholas Chieh Wu¹⁰，Yiming Guo¹¹，Dianyun Hou¹²，Jin Pei¹，Jihai Gao¹，Yan Hua¹³，Zhihai Huang⁴，Shilin Chen^1,2（Institute of Herbgenomics，State Key Laboratory of Southwest Chinese Medicine Resources，Pharmacy College，Chengdu University of Traditional Chinese Medicine；Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；Key Laboratory of Cancer Prevention and Therapy Combining Traditional Chinese and Western Medicine of Zhejiang Province，Zhejiang Academy of Traditional Chinese Medicine，Tongde Hospital of Zhejiang Province；Guangdong Provincial Hospital of Chinese Medicine(the Second Clinical Medical College of Guangzhou University of Chinese Medicine，Guangdong Provincial Hospital of Traditional Chinese Medicine)；Pharmacy College，Shandong University of Traditional Chinese Medicine；Department of Pathology，Memorial Sloan Kettering Cancer Center；Beijing Engineering Research Center of Pediatric Surgery，Engineering and Transformation Center，Beijing Children’s Hospital，National Center for Children’s Health，Capital Medical University；School of Basic Medical Sciences，Peking University；School of Chinese Materia Medica，Tianjin University of Traditional Chinese Medicine；School of Life and Environmental Sciences，the University of Sydney；University of Pittsburgh，Kenneth P.Dietrich School of Arts and Sciences；Agricultural College，Henan University of Science and Technology；Guangdong Provincial Key Laboratory of Silviculture，Protection and Utilization，Guangdong Academy of Forestry）.Genomic, transcriptomic, and epigenomic analysis of a medicinal snake, Bungarus multicinctus, to provides insights into the origin of Elapidae neurotoxins[J].Acta Pharmaceutica Sinica B,2023,第5期 Binghe Xu¹，Qingyuan Zhang²，Xichun Hu³，Qing Li¹，Tao Sun⁴，Wei Li⁵，Quchang Ouyang⁶，Jingfen Wang⁷，Zhongsheng Tong⁸，Min Yan⁹，Huiping Li¹⁰，Xiaohua Zeng¹¹，Changping Shan¹²，Xian Wang¹³，Xi Yan¹⁴，Jian Zhang³，Yue Zhang²，Jiani Wang¹，Liang Zhang⁴，Ying Lin¹⁵，Jifeng Feng¹⁶，Qianjun Chen¹⁷，Jian Huang¹⁸，Lu Zhang¹⁹，Lisong Yang¹⁹，Ying Tian¹⁹，Hongyan Shang¹⁹（Department of Medical Oncology and State Key Laboratory of Molecular Oncology，National Cancer Cener/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Medical Oncology，Harbin Medical University Cancer Hospital；Department of Medical Oncology，Fudan University Shanghai Cancer Center；Department of Galactophore，Liaoning Cancer Hospital & Institute；Department of Oncology，the First Hospital of Jilin University；Department of Galactophore，Hunan Cancer Hospital；Department of Galactophore，Linyi Cancer Hospital；Department of Breast Medical Oncology，Tianjin Medical University Cancer Institute & Hospital；Department of Breast Disease，Henan Breast Cancer Center，the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital；Department of Breast Oncology，Beijing Cancer Hospital；Breast Cancer Center，Chongqing University Cancer Hospital；Department of Breast and Thyroid Oncology，Affiliated Hospital of Jining Medical University；Department of Medical Oncology，Run Run Shaw Hospital，Affiliated Hospital of Zhejiang University；Department of Head and Heck Oncology，West China Hospital，Sichuan University；Department of Thyroid & Breast Surgery，the First Affiliated Hospital of Sun Yat-sen University；Department of Medical Oncology，Jiangsu Cancer Hospital；Department of Galactophore，Guangdong Hospital of Traditional Chinese Medicine；Department of Oncological Surgery，the Second Affiliated Hospital，Zhejiang University School of Medicine；Taizhou EOC Pharma Co.Ltd.）.Entinostat, a class Ⅰ selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer：A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial[J].Acta Pharmaceutica Sinica B,2023,第5期 Mingyan Li¹，Yaling Wang^1,2，Lingzhi Zhang¹，Changxing Gao¹，Jing J.Li¹，Jiandong Jiang¹，Qing Zhu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，and Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study，Chinese Academy of Medical Sciences and Peking Union Medical College；College of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Utilization，Yunnan University of Chinese Medicine）.Berberine improves central memory formation of CD8⁺ T cells：Implications for design of natural product-based vaccines[J].Acta Pharmaceutica Sinica B,2023,第5期 Huiyang Wang，Yueyang Liu，Zhenkun Guo，Minghui Cui，Peng Pang，Jingyu Yang，Chunfu Wu（Department of Pharmacology，Shenyang Pharmaceutical University）.Enhancement of oligodendrocyte autophagy alleviates white matter injury and cognitive impairment induced by chronic cerebral hypoperfusion in rats[J].Acta Pharmaceutica Sinica B,2023,第5期 Rolande Meudom^1,2，Yanxian Zhang¹，Michael A.Vanden Berg³，Lei Zou³，Yi Wolf Zhang^1,2，Matthew J.Webber³，Danny Hung-Chieh Chou¹（Division of Endocrinology and Diabetes，Department of Pediatrics，School of Medicine，Stanford University；Department of Biochemistry，School of Medicine，University of Utah；Department of Chemical Engineering，University of Notre Dame）.Supramolecular approaches for insulin stabilization without prolonged duration of action[J].Acta Pharmaceutica Sinica B,2023,第5期 Jinmiao Lu，Hao Liu²，Qingtong Zhou^3,4，Ming-Wei Wang^3,4，Zhiping Li（Department of Pharmacy，Children’s Hospital of Fudan University，National Children’s Medical Center；School of Medicine，Ningbo University；Research Center for Deepsea Bioresources；Department of Pharmacology，School of Basic Medical Sciences，Fudan University）.A potentially serious adverse effect of GLP-1 receptor agonists[J].Acta Pharmaceutica Sinica B,2023,第5期 Shuo Han^1,2，Xinru Chen¹，Leaf Huang¹（Division of Pharmacoengineering and Molecular Pharmaceutics，Eshelman School of Pharmacy，University of North Carolina at Chapel Hill；Department of Toxicology，Guangdong Provincial Key Laboratory of Tropical Disease Research，School of Public Health，Southern Medical University）.The tumor therapeutic potential of long non-coding RNA delivery and targeting[J].Acta Pharmaceutica Sinica B,2023,第4期 Jiaxuan He¹，Qiao Duan^1,2，Chunyan Ran¹，Ting Fu^1,3，Yuan Liu¹，Weihong Tan^1,3,2（The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)，The Key Laboratory of Zhejiang Province for Aptamers and Theranostics，Hangzhou Institute of Medicine(HIM)，Chinese Academy of Sciences；Institute of Molecular Medicine(IMM)，Renji Hospital，Shanghai Jiao Tong University School of Medicine，and College of Chemistry and Chemical Engineering，Shanghai Jiao Tong University；Molecular Science and Biomedicine Laboratory(MBL)，State Key Laboratory of Chemo/Biosensing and Chemometrics，College of Chemistry and Chemical Engineering，College of Biology，Aptamer Engineering Center of Hunan Province，Hunan University）.Recent progress of aptamer-drug conjugates in cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Libin Pan，Hang Yu，Jie Fu，Jiachun Hu，Hui Xu，Zhengwei Zhang，Mengmeng Bu，Xinyu Yang，Haojian Zhang，Jinyue Lu，Jiandong Jiang，Yan Wang（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences/Peking Union Medical College）.Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota[J].Acta Pharmaceutica Sinica B,2023,第4期 Sili Zheng¹，Zhiyong Li¹，Jie Song¹，Pin Wang¹，Jian Xu²，Wenjun Hu¹，Yi Shi³，Qi Qi¹，Zhuwei Miao¹，Yunfeng Guan¹，Chaoyu Miao¹（Department of Pharmacology，Second Military Medical University/Naval Medical University；Changhai Hospital，Second Military Medical University/Naval Medical University；Zhongshan Hospital，Fudan University）.Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis[J].Acta Pharmaceutica Sinica B,2023,第4期 Zhihui Han¹，Xiang Gao²，Yuanjie Wang¹，Shuning Cheng¹，Xiaoyan Zhong³，Yong Xu⁴，Xiaozhong Zhou²，Zengli Zhang³，Zhuang Liu¹，Liang Cheng¹（Institute of Functional Nano & Soft Materials(FUNSOM)，Collaborative Innovation Center of Suzhou Nano Science and Technology，Soochow University；Department of Orthopedics，The Second Affiliated Hospital of Soochow University；Department of Environmental Health，School of Public Health，Soochow University；School of Materials and Energy，Guangdong University of Technology）.Ultrasmall iron-quercetin metal natural product nanocomplex with antioxidant and macrophage regulation in rheumatoid arthritis[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoxi Lv¹，Shanshan Liu²，Chang Liu，Yunxuan Li⁴，Tingting Zhang⁴，Jie Qi⁵，Ke Li⁴，Fang Hua¹，Bing Cui¹，Xiaowei Zhang¹，Yuxin Liu¹，Jiaojiao Yu¹，Jinmei Yu¹，Li Li¹，Xia Li⁵，Zhigang Yao⁶，Bo Huang⁷（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；National Clinical Research Center for Metabolic Diseases，Key Laboratory of Diabetes Immunology，Ministry of Education，And Department of Metabolism and Endocrinology，The Second Xiangya Hospital of Central South University；Drug Clinical Trial Institution，Children’s Hospital，Capital Institute of Pediatrics；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences & Peking Union Medical College；Shandong University；Department of Respiratory Medicine，Beijing Friendship Hospital，Capital Medical University；Institute of Basic Medicine，Chinese Academy of Medical Sciences & Peking Union Medical College）.TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2[J].Acta Pharmaceutica Sinica B,2023,第4期 Nasir Uddin^1,2,3，Daniel W.Binzel^1,2,3，Dan Shu^1,2,3，Tian-Min Fu⁴，Peixuan Guo^1,2,3（Center for RNA Nanobiotechnology and Nanomedicine，Division of Pharmaceutics and Pharmacology，College of Pharmacy，the Ohio State University；Dorothy M.Davis Heart and Lung Research Institute，the Ohio State University；James Comprehensive Cancer Center，College of Medicine，the Ohio State University；Department of Biological Chemistry & Pharmacology，College of Medicine，the Ohio State University）.Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome[J].Acta Pharmaceutica Sinica B,2023,第4期 Kamila Butowska^1,2，Xuexiang Han¹，Ningqiang Gong¹，Rakan El-Mayta¹，Rebecca M.Haley¹，Lulu Xue¹，Wenqun Zhong³，Wei Guo³，Karin Wang⁴，Michael J.Mitchell^1,5,6,7,8（Department of Bioengineering，University of Pennsylvania；Intercollegiate Faculty of Biotechnology，University of Gda nsk & Medical University of Gda nsk；Department of Biology，University of Pennsylvania；Department of Bioengineering，Temple University；Abramson Cancer Center，Perelman School of Medicine，University of Pennsylvania；Institute for Immunology，Perelman School of Medicine，University of Pennsylvania；Cardiovascular Institute，Perelman School of Medicine，University of Pennsylvania；Institute for Regenerative Medicine，Perelman School of Medicine，University of Pennsylvania）.Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期首页上一页 5 6 7 8 9 下一页尾页共有11页，转到页

期刊文章列表